Gedeon Richter picks up range of branded generic OCs

The UK subsidiary of Hungarian drugmaker Gedeon Richter (RICHT: HB) today announced that full marketing and distribution rights to an oral contraceptive range of branded generics, acquired from Ireland-headquartered Consilient Health, have been transferred to the company.

Under the terms of the transfer, Gedeon Richter has become the Marketing Authorization holder in the UK for all the products within the range. The cash purchase price amounts to £32.5million ($40.6 million).

The branded generics portfolio includes seven combined oral contraceptives and one progestogen-only pill, containing ethinylestradiol and marketed under brands such as Gedareal, Lucette, Millinette, Rigevidone, and Trirgol, and Cerelle which contains desogestrel.